Evaluation of MTA Versus Biodentine as Pulpotomy Agents in Immature First Permanent Molars

Carious Exposure of Pulp Clinical Trial

Official title:

Clinical and Radiographic Evaluation of MTA Versus Biodentine as Pulpotomy Agents in Immature First Permanent Molars: A Randomized Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03838094
• Other study ID #: 19119
• Status: Completed
• Phase: Phase 1/Phase 2
• Start date: February 2016
• Est. completion date: September 2018

Study information

• Verified date: February 2019
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Aim of the study: To compare the clinical and radiographic outcomes of mineral trioxide aggregate (MTA) and Biodentine as vital pulp therapy materials (pulpotomy) of cariously exposed vital immature mandibular first permanent molars.

Materials and Methods: sixty immature first mandibular permanent molars cariously exposed with symptomatic /asymptomatic pulpitis were included in the study according to inclusion criteria and were equally divided in two groups. Following split-mouth design molars were randomly assigned to either a control group (MTA 30 molars) or a test group (Biodentine 30 molars). After conducting pulpotomy and covering pulp stumps with the MTA and Biodentine, treated molars received permanent restorations. Blinded clinical and radiographic evaluations were performed at different time intervals (base line immediate postoperative, 6, 12 and 18 months) according to clinical and radiographic criteria of success. Data were recorded and analysed.

Description:

Diagnosis:

1. Full history data will be collected, including personal, medical and previous dental data

2. Clinical examination using mirror and probe to assess the inclusion criteria.

3. Radiographic examination using preoperative digital periapical radiograph to assess the inclusion criteria.

4. Preoperative photograph will be taken.

Operative procedure:

Experimental group:

1. Injection of local anesthesia and rubber dam isolation.

2. caries and roof of the pulp chamber will be removed by a fissure diamond bur (Diatech, Heerbrug, Switzerland) and high-speed handpiece with coolant.

3. The pulps will be amputated to the orifice level using a long-shank diamond round bur.

4. Haemostasis will be achieved by gentle placement of a saline-moistened cotton pellet over amputated pulps for 5-10 min.

5. Calcium silicate-based BiodentineTM (Septodont Ltd., Saint Maur des Fausse´s, France) will be mixed according to the manufacturer's instructions, radicular pulp will be covered by the material using a wet cotton pellet.

6. A self-cure glass ionomer (GC; GC Corporation, Tokyo, Japan) will be placed over the pulpotomy agent as a final restoration.

7. Immediate post-operative radiograph and photograph will be taken.

Control group:

The same procedures will be carried out as the experimental group, but the pulp stumps will be covered with fast-setting mineral trioxide aggregate (MTA) ENDOCEM MTA (Maruchi, Wonju, Korea) and will be prepared according to the manufacturer's instructions. A 3-mm-thick layer of MTA will be placed over the amputated pulps and will be gently adapted to the dentinal walls using a wet cotton pellet. A self-cure glass ionomer (GC; GC Corporation, Tokyo, Japan) will be placed over the pulpotomy agent as a final restoration.

Postoperative care:

Instructions to avoid lip and cheek biting in addition to oral hygiene measures.

Follow up:

Assess the outcomes clinically and radiographically at (baseline, 6, 12 and 18 months).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: September 2018
• Est. primary completion date: August 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 7 Years to 8 Years

Eligibility

Inclusion Criteria:

• Bilaterally Symptomatic / asymptomatic vital immature mandibular first permanent molars (with clinical carious exposure of the pulp and presence of bleeding upon exposure)

• Patients with an age range from 7-8 years.

• Absence of sinus tract, soft tissue swelling.

Exclusion Criteria:

• • Molars were excluded if non-restorable.

• excessive mobility (more than 1 mm horizontally).

• Radiographic evidence of peri- and /or inter-radicular lesions, internal/ external root resorption, pulp/ canal calcifications.

Related Conditions & MeSH terms

• Carious Exposure of Pulp

Intervention

Biological:
• Biodentine
it is a dentin substitute, a new biologically active material facilitates its penetration through opened dentinal tubules to crystallize interlocking with dentin and provide mechanical properties.
• MTA
MTA is a powder that consists of fine hydrophilic particles that set in the presence of moisture. MTA consists of tricalcium silicate, tricalcium aluminate, tricalcium oxide and silicate oxide. MTA was considered a remarkable biocompatible material with various clinical applications that include surgical and non-surgical applications such as pulp capping

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Gihan M Abuelniel ,PhD	Cairo University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	pain, sensitivity to percussion/ palpation	by asking the patient( binary measure)Yes or No, where Yes indicates presence of pain that shows clinical failure	18 months
Primary	Swelling or sinus tract	by visual examination( Binary measure) (Yes or No) where No indicates success of the treatment	18 months
Primary	tooth mobility	by back of the mirror( Binary measure) (Yes or No) where No mobility indicates success of the treatment	18 months
Secondary	root formation/development stage	by radiographic parallel technique to measure the maturity scores used during the radiographic assessment of root development are F, G and H (where F is the worse and H is the best stage)	18 months
Secondary	Crown: Root ratio	by radiographic parallel technique ( the ratio 2:1 or more than 2:1) the ratio more than 2:1 is the best	18 months
Secondary	Apical closure	by radiographic parallel technique( the apex is blunder apex ,partially open, or constricted) blunder apex is the worse and constricted apex is the best.	18 months
Secondary	presence of radiolucency	by radiographic parallel technique( binary measure)( yes or No) if radiolucency is detected this indicates failure of the treatment	18 month